Catherine Abrial
Clermont-ferrand, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Circulating proteins as biomarkers of response to cancer immunotherapy (Review).
Journal: International journal of oncology
Published: September 24, 2025
Study Protocol for Assessment of the Feasibility of an Intraoperative Localization Technique Using Augmented Reality in Breast-Conserving Surgery for Non-Palpable Cancer Lesions: A Feasibility Study.
Journal: Health science reports
Published: September 09, 2025
Identification of serum proteins associated with response of triple-negative breast cancer to neoadjuvant chemotherapy: preliminary results from the INSTIGO trial.
Journal: Clinical proteomics
Published: July 30, 2025
Exploring screening practices for sexual disorders in breast cancer patients
Journal: Soins; la revue de reference infirmiere
Published: June 07, 2025
Patient-reported satisfaction with thermal water-based cosmetic products in breast cancer patients undergoing chemotherapy: a feasibility study.
Journal: Cancer treatment and research communications
Published: May 27, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.
Journal: Cancer epidemiology
Published: November 20, 2024
Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study.
Journal: Anticancer research
Published: September 03, 2024
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial.
Journal: BMC cancer
Published: January 09, 2024
Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial.
Journal: BMC cancer
Published: October 16, 2023
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.
Journal: Frontiers in oncology
Published: April 01, 2021
Last Updated: 09/26/2026